In Nordic countries 30-day mortality rate is half that estimated with EuroSCORE II in high-risk adult patients given aprotinin and undergoing mainly complex cardiac procedures-Reference-Cited by-同舟云学术

In Nordic countries 30-day mortality rate is half that estimated with EuroSCORE II in high-risk adult patients given aprotinin and undergoing mainly complex cardiac procedures

Published:2024-03-31 Issue:1 Volume:58 Page:
ISSN:1401-7431
Container-title:Scandinavian Cardiovascular Journal
language:en
Short-container-title:Scandinavian Cardiovascular Journal

Author:

van der Linden Jan¹,Fux Thomas²,Kaakinen Timo³,Rutanen Juha⁴,Toivonen Jenni M.⁵,Nyström Fredrik⁶,Wahba Alexander⁷,Hammas Bengt⁸,Parviainen Maria⁹,Cunha-Goncalves Doris¹⁰,Hiippala Seppo¹¹

Affiliation:

1. Department of Physiology and Pharmacology, Karolinska Institute, Stockholm, Sweden

2. Department of Surgery and Molecular Medicine, Karolinska Institute, Stockholm, Sweden

3. Research Group of Surgery, Anesthesiology and Intensive Care Medicine, Medical Research Center Oulu, Oulu University Hospital, University of Oulu, Oulu, Finland

4. Department of Anesthesiology, Kuopio University Hospital, Kuopio, Finland

5. Department of Anesthesiology, Turku University Hospital, Turku, Finland

6. Department of Anesthesiology, Norrland’s University Hospital, Umeå, Sweden

7. Department of Cardiothoracic Surgery , Trondheim University Hospital, Trondheim, Norway

8. Department of Anesthesiology, Örebro University Hospital, Örebro, Sweden

9. Department of Anesthesiology, Tampere University Hospital, Tampere, Finland

10. Department of Anesthesiology, Skånes Universitetssjukhus, Lund, Sweden

11. Department of Anesthesiology, Helsinki University Hospital, Helsinki, Finland

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/14017431.2024.2330347

Reference19 articles.

1. Summary of Product Characteristics: trasylol® (aprotinin). 2013. [cited 2023 April 5]. https://www.medicines.org.uk/emc/product/2472

2. EFFECT OF APROTININ ON NEED FOR BLOOD TRANSFUSION AFTER REPEAT OPEN-HEART SURGERY

3. The Risk Associated with Aprotinin in Cardiac Surgery

4. Aprotinin during Coronary-Artery Bypass Grafting and Risk of Death

5. The Effect of Aprotinin on Outcome after Coronary-Artery Bypass Grafting